Vita Dr. Claudio Mussolino
Group Leader Genome and Epigenome Engineering|
Since Nov. 2018 |
Group Leader “Genome and Epigenome Engineering”, Institute for Transfusion Medicine and Gene Therapy - Medical Center - University of Freiburg |
|
2012-2018 |
Junior Group Leader “Genome Engineering”, Institute for Cell and Gene Therapy and Center for Chronic Immunodeficiency (CCI) - University Medical Center Freiburg |
|
2010-2012 |
Post-doctoral fellow, Hannover Medical School, Institute of Experimental Hematology |
|
2010 |
PhD: Mutation–independent treatment of autosomal dominant retinitis pigmentosa (ADRP) by artificial transcription factors silencing the human rhodopsin gene |
|
2005-2010 |
PhD student Molecular Medicine, European School of Molecular Medicine, University Federico II and TIGEM Institute, Neapel |
|
2005 |
Research Assistent, Istituto Nazionale Tumori, Neapel |
|
1999-2004 |
Master Studies Molecular Biology, University Federico II, Neapel |
Dr. Claudio Mussolino
Group Leader
MEDICAL CENTER - UNIVERSITY OF FREIBURG
Institute for Transfusion Medicine and Gene Therapy
at Center for Translational Cell Research
Breisacher Straße 115
79106 Freiburg
Phone +49 761 270 77738
Fax +49 761 270 77744